Citations

Clear

904 citation(s) found for "Gordon, S".

Values and preferences for oral antithrombotic therapy in patients with atrial fibrillation: physician and patient perspectives
Alonso‐Coello, Pablo , Montori, Víctor M. , Díaz, Mireya , Dalmau, Gemma Mas , Díez, A.I. Fernández, Solà, Iván , Roura, Mercè, Souto, Juan Carlos , Oliver, Sven, Ruíz, Rafael Azuar , Coll‐Vinent, Blanca , Gich, Ignasi , Schünemann, Holger J. , Devereaux, P.J. , Guyatt, Gordon , Montori, Victor M , Schünemann, Holger J , Carlos Souto, Juan , Alonso-Coello, Pablo

Mayo Clinic

Health Expectations | May 12, 2014 | Volume: 18 | Issue: 6 | Pages: 2318-2327

10.1111/hex.12201 | PMID 24813058 Get It

AbstractBackgroundExploration of values and preferences in the context of anticoagulation therapy for atrial fibrillation (AF) remains limited. To better characterize the distribution of patient and physician values and preferences relevant to decisions regarding anticoagulation in patients with AF, we conducted interviews with patients at risk of developing AF and physicians who manage patients with AF.MethodsWe interviewed 96 outpatients and 96 physicians in a multicenter study and elicited the maximal increased risk of bleeding (threshold risk) that respondents would tolerate with warfarin vs. aspirin to achieve a reduction in three strokes in 100 patients over a 2‐year period. We used the probabilistic version of the threshold technique.ResultsThe median threshold risk for both patients and physicians was 10 additional bleeds (10 P = 0.7). In both groups, we observed large variability in the threshold number of bleeds, with wider variability in patients than clinicians [patient range: 0–100, physician range: 0–50]. We observed one cluster of patients and physicians who would tolerate <10 bleeds and another cluster of patients, but not physicians, who would accept more than 35.ConclusionsOur findings suggest wide variability in patient and physician values and preferences regarding the trade‐off between strokes and bleeds. Results suggest that in individual decision making, physician and patient values and preferences will often be discordant; this mandates tailoring treatment to the individual patient's preferences.
Intraoperative image-guided spinal navigation: technical pitfalls and their avoidance
Rahmathulla, Gazanfar , Nottmeier, Eric W. , Pirris, Stephen M. , Deen, H. Gordon , Pichelmann, Mark A.

Mayo Clinic

Neurosurgical Focus | March 1, 2014 | Volume: 36 | Issue: 3 | Pages: E3

10.3171/2014.1.focus13516 | PMID 24580004 Get It

Spinal instrumentation has made significant advances in the last two decades, with transpedicular constructs now widely used in spinal fixation. Pedicle screw constructs are routinely used in thoracolumbar-instrumented fusions, and in recent years, the cervical spine as well. Three-column fixations with pedicle screws provide the most rigid form of posterior stabilization. Surgical landmarks and fluoroscopy have been used routinely for pedicle screw insertion, but a number of studies reveal inaccuracies in placement using these conventional techniques (ranging from 10% to 50%). The ability to combine 3D imaging with intraoperative navigation systems has improved the accuracy and safety of pedicle screw placement, especially in more complex spinal deformities. However, in the authors' experience with image guidance in more than 1500 cases, several potential pitfalls have been identified while using intraoperative spinal navigation that could lead to suboptimal results. This article summarizes the authors' experience with these various pitfalls using spinal navigation, and gives practical tips on their avoidance and management.
The impact of hepatitis C burden: an evidence‐based approach
Younossi, Zobair M. , Kanwal, Fasiha , Saab, Sammy , Brown, Kimberly , El‐Serag, Hashem B. , Kim, W. Ray , Kugelmas, Marcelo , Kanwal, Fasiha , Ahmed, Aijaz , Gordon, Stuart C.

Mayo Clinic

Alimentary Pharmacology & Therapeutics | January 27, 2014 | Volume: 39 | Issue: 5 | Pages: 518-531

10.1111/apt.12625 | PMID 24461160 Get It

SummaryBackgroundInfection with the hepatitis C virus (HCV) has been considered a major cause of mortality, morbidity and resource utilisation in the US. In addition, HCV is the main cause of hepatocellular cancer (HCC) in the US. Recent developments in the diagnosis and treatment of HCV, including new recommendations pertaining to screening for HCV by the Centers for Disease Control and Prevention and newer treatment regimens with high efficacy, short duration and the potential for interferon‐free therapies, have energised the health care practitioners regarding HCV management.AimTo assess the full impact of HCV burden on clinical, economic and patient‐reported outcomes.MethodsAn expert panel was convened to assess the full impact of HCV burden on a number of important outcomes using an evidence‐based approach predicated on Grading of Recommendations Assessment, Development and Evaluation methodology. The literature was summarised, graded using an evidence‐based approach and presented during the workshop. Workshop presentations were intended to review recent, relevant evidence‐based literature and provide graded summary statements pertaining to HCV burden on topics including the relationships between HCV and the development of important outcomes.ResultsThe associations of HCV with cirrhosis, HCC, liver‐related mortality, type 2 diabetes mellitus, rheumatological diseases and quality of life impairments are supported by strong evidence. Also, there is strong evidence that sustained viral eradication of HCV can improve important outcomes such as mortality and quality of life.ConclusionsThe current evidence suggests that HCV has been associated with tremendous clinical, economic and quality of life burden.
Thyroid Hormone-Responsive Pituitary Hyperplasia Independent of Somatostatin Receptor 2
Brinkmeier, Michelle L. , Stahl, Justin H., Gordon, David F. , Ross, Brian D. , Sarapura, Virginia D. , Dowding, Janet M., Lloyd, Ricardo V., Ridgway, E. Chester, Camper, Sally A. , Kendall, Susan K.

Mayo Clinic

Molecular Endocrinology | January 8, 2014 | Volume: 15 | Issue: 12 | Pages: 2129-2136

10.1210/mend.15.12.0744 | PMID 11731614 Get It

AbstractMice homozygous for the targeted disruption of the glycoprotein hormone α-subunit (αGsu) display hypertrophy and hyperplasia of the anterior pituitary thyrotropes. Thyrotrope hyperplasia results in tumors in aged αGsu−/− mice. These adenomatous pituitaries can grow independently as intrascapular transplants in hypothyroid mice, suggesting that they have progressed beyond simple hyperplasia. We used magnetic resonance imaging to follow the growth and regression of thyrotrope adenomatous hyperplasia in response to thyroid hormone treatment and discovered that the tumors retain thyroid hormone responsiveness. Somatostatin (SMST) and its diverse receptors have been implicated in cell proliferation and tumorigenesis. To test the involvement of SMST receptor 2 (SMSTR2) in pituitary tumor progression and thyroid hormone responsiveness in αGsu−/− mutants, we generated Smstr2−/−, αGsu−/− mice. Smstr2−/−, αGsu−/− mice develop hyperplasia of thyrotropes, similar to αGsu−/− mutants, demonstrating that SMSTR2 is dispensable for the development of pituitary adenomatous hyperplasia. Thyrotrope hyperplasia in Smstr2−/−, αGsu−/− mice regresses in response to T4 treatment, suggesting that SMSTR2 is not required in the T4 feedback loop regulating TSH secretion.
Genetically dictated change in host mucus carbohydrate landscape exerts a diet-dependent effect on the gut microbiota
Kashyap, Purna , Marcobal, Ángela, Ursell, Luke K., Smits, Samuel A. , Sonnenburg, Erica D. , Costello, Elizabeth K. , Higginbottom, Steven K. , Domino, Steven E. , Holmes, Susan , Relman, David A. , Knight, Rob , Gordon, Jeffrey I. , Sonnenburg, Justin L.

Mayo Clinic

Proceedings of the National Academy of Sciences | September 24, 2013 | Volume: 110 | Issue: 42 | Pages: 17059-17064

10.1073/pnas.1306070110 | PMID 24062455 Get It

Significance Our data demonstrate that differences in host genotype that affect the carbohydrate landscape of the distal gut interact with diet to alter the composition and function of resident microbes in a diet-dependent manner.
051 Can We Automatically Produce Generic Decision Aids for the Clinical Encounter Directly from GRADE Guideline Recommendations? Experience from the Share-It Project
Brandt, Linn , Heen, A Anja, Kristiansen, A, Neumann, I, Montor, V, Vandvik, Per Olav , Agoritsas, Thomas , Alonso‐Coello, Pablo , Akl, Elie A. , Tikkinen, Kari A.O. , Guyatt, Gordon

Mayo Clinic

BMJ Quality & Safety | August 15, 2013 | Volume: 22 | Issue: Suppl 1 | Pages: A28.2-A28

10.1136/bmjqs-2013-002293.82 Get It

Background Although decision aids (DA) can help to communicate evidence to patients, their production is time consuming, often not based on the best available evidence or rapidly outdated. Linking trustworthy guidelines and DA for shared-decision making could both overcome these limitations and enhance guideline dissemination. Objectives To test the feasibility of automatically translating any recommendations from GRADE guidelines into generic and interactive DA accessible on tablet computers for clinicians and their patients in the clinical encounter. Methods As part of the DECIDE project, we developed a framework for translating components of GRADE into DA, following the International Patient Decision Aid Standards. Using a recently published guideline, we implemented that framework in our MAGIC (Making Grade the Irresistible Choice) application – a prototype electronic guideline tool and publication platform that can automatically display recommendations in multilayered presentation formats. Results Our prototype was able to automatically translate a large number of GRADE recommendations and their supporting evidence into electronic and interactive DA. Preliminary results of user-testing in real patient-clinician interactions suggest that these DA can be used at the point of care to discuss estimates of treatment effects for patient relevant outcomes, confidence in estimates, burden of treatment, and cost issues. Discussion This study provides a proof-of-concept that components of GRADE recommendations can be interactively displayed in generic tools for interactive shared-decision making in a wide range of treatment alternatives. Implications for Guideline Developers/Users Our electronic DA offer promising opportunities to disseminate guidelines at the point of care.
081 The Endocrine Society Guidelines: Implications of Strong Recommendations with Low Quality Evidence
Domecq, Juan Pablo , Guyatt, Gordon, Britto, Jorge , Murad, M. Hassan , Montori, Víctor M.

Mayo Clinic

BMJ Quality & Safety | August 15, 2013 | Volume: 22 | Issue: Suppl 1 | Pages: A38.2-A38

10.1136/bmjqs-2013-002293.112 Get It

Background In 2005, the Endocrine Society (TES) adopted the GRADE system of developing clinical practice guidelines. This system facilitates the formulation of evidence-based recommendations by explicitly describing the confidence in estimates (quality of evidence) and strength of each recommendation. Objectives To describe and characterise the relationship between confidence in estimates and strength of recommendation in TES guidelines. Methods We included all published TES guidelines between 2005 (when TES started using GRADE) and 2011. Independently and in duplicate, reviewers extracted, for each recommendation: disease area, confidence in estimates and design of the studies considered, and strength of recommendation. In strong recommendations with low quality of we developed and applied a taxonomy of appropriate recommendations and identified those we considered inappropriate. Results Most of the 357 recommendations issued were supported by evidence warranting low or very low confidence in estimates (256, 72%). Evidence cited in support of these recommendations came exclusively from observational studies in 233 recommendations (65%). Most recommendations were strong (206, 58%); of these, 121 (59%) were supported by evidence warranting low or very low confidence in estimates. In 101/121 (83%), we identified a compelling rationale for the recommendations; in 20 (17%), we did not. Conclusions Most TES strong recommendation based on low quality evidence are justified and appropriate, but a substantial proportion are not. Implications for Guideline Developers Guideline developers should carefully justify any strong recommendations based on low confidence in effect estimates.
Overdrainage shunt complications in idiopathic normal-pressure hydrocephalus and lumbar puncture opening pressure
Khan, Qurat ul Ain , Wharen, Robert E. , Thomas, Colleen S. , Deen, H. Gordon , Reimer, Ronald, Gerpen, Jay A. van, Graff‐Radford, Neill R. , Grewal, Sanjeet S. , Crook, Julia E.

Mayo Clinic

Journal of Neurosurgery | August 9, 2013 | Volume: 119 | Issue: 6 | Pages: 1498-1502

10.3171/2013.7.jns13484 | PMID 23930853 Get It

Object Management of idiopathic normal-pressure hydrocephalus (iNPH) is hard because the diagnosis is difficult and shunt surgery has high complication rates. An important complication is overdrainage, which often can be treated with adjustable–shunt valve manipulations but also may result in the need for subdural hematoma evacuation. The authors evaluated shunt surgery overdrainage complications in iNPH and their relationship to lumbar puncture opening pressure (LPOP). Methods The authors reviewed the charts of 164 consecutive patients with iNPH who underwent shunt surgery at their institution from 2005 to 2011. They noted age, sex, presenting symptoms, symptom duration, hypertension, body mass index (BMI), imaging findings of atrophy, white matter changes, entrapped sulci, LPOP, valve opening pressure (VOP) setting, number of valve adjustments, serious overdrainage (subdural hematoma requiring surgery), radiological overdrainage (subdural hematomas or hygroma seen on postoperative imaging), clinical overdrainage (sustained or postural headache), other complications, and improvements in gait, urine control, and memory. Results Eight patients (5%) developed subdural hematomas requiring surgery. All had an LPOP of greater than 160 mm H2O and an LPOP-VOP of greater than 40 mm H2O. Radiological overdrainage was more common in those with an LPOP of greater than 160 mm H2O than in those with an LPOP of less than 160 mm H2O (38% vs 21%, respectively; p = 0.024). The BMI was also significantly higher in those with an LPOP of greater than 160 mm H2O (median 30.2 vs 27.0, respectively; p = 0.005). Conclusions Serious overdrainage that caused subdural hematomas and also required surgery after shunting was related to LPOP and LPOP-VOP, which in turn were related to BMI. If this can be replicated, individuals with a high LPOP should have their VOP set close to the LPOP, or even higher. In doing this, perhaps overdrainage complications can be reduced.
Autologous haematopoietic cell transplantation for non‐Hodgkin lymphoma with secondary CNS involvement
Wang, Zhiwei , Zhang, Mei‐Jie , Bolwell, Brian J., Chen, Andy I. , Fenske, Timothy S. , Freytes, César O. , Gibson, John, Hayes‐Lattin, Brandon , Holmberg, Leona , Inwards, David J. , Isola, Luis , Khoury, H. Jean , Lewis, Victor , Maharaj, Dipnarine , Munker, Reinhold , Phillips, Gordon L., Rizzieri, David A. , Rowlings, Philip A., Saber, Wael , Satwani, Prakash , Waller, Edmund K. , Maloney, David G. , Montoto, Silvia , Laport, Ginna G. , Hari, Parameswaran , Holmberg, Leona , Chen, Andy , Maziarz, Richard Thomas , Gale, Robert Peter , Vose, Julie M. , Lazarus, Hillard M. , Waller, Edmund K , Montoto, Silvia , Hari, Parameswaran

Mayo Clinic

British Journal of Haematology | July 6, 2013 | Volume: 162 | Issue: 5 | Pages: 648-656

10.1111/bjh.12451 | PMID 23829536 Get It

SummaryPre‐existing central nervous system (CNS) involvement may influence referral for autologous haematopoietic cell transplantation (AHCT) for patients with non‐Hodgkin lymphoma (NHL). The outcomes of 151 adult patients with NHL with prior secondary CNS involvement (CNS+) receiving an AHCT were compared to 4688 patients without prior CNS lymphoma (CNS−). There were significant baseline differences between the cohorts. CNS+ patients were more likely to be younger, have lower performance scores, higher age‐adjusted international prognostic index scores, more advanced disease stage at diagnosis, more aggressive histology, more sites of extranodal disease, and a shorter interval between diagnosis and AHCT. However, no statistically significant differences were identified between the two groups by analysis of progression‐free survival (PFS) and overall survival (OS) at 5 years. A matched pair comparison of the CNS+ group with a subset of CNS− patients matched on propensity score also showed no differences in outcomes. Patients with active CNS lymphoma at the time of AHCT (n = 55) had a higher relapse rate and diminished PFS and OS compared with patients whose CNS lymphoma was in remission (n = 96) at the time of AHCT. CNS+ patients can achieve excellent long‐term outcomes with AHCT. Active CNS lymphoma at transplant confers a worse prognosis.